News | August 03, 2022
Jubilant Pharmova gets 6 observations from USFDA for its facility at Roorkee
he US FDA has issued six observations pursuant to the completion of the audit.
he US FDA has issued six observations pursuant to the completion of the audit.
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Subscribe To Our Newsletter & Stay Updated
